The many faces of c-MYC. (Q35189740)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12893289%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

review article

1 reference

title

The many faces of c-MYC (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12893289%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12893289%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

author name string

Stella Pelengaris

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12893289%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

language of work or name

English

0 references

publication date

1 August 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12893289%20AND%20SRC:MED&resulttype=core&format=json

Archives of Biochemistry and Biophysics

6 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12893289%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

416

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12893289%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12893289%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

129-136

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12893289%20AND%20SRC:MED&resulttype=core&format=json

MYC oncogenes and human neoplastic disease

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900294-7

Influence of increased c-Myc expression on the growth characteristics of human melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900294-7

A large scale genetic analysis of c-Myc-regulated gene expression patterns

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900294-7

Suppression of Myc-induced apoptosis in beta cells exposes multiple oncogenic properties of Myc and triggers carcinogenic progression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900294-7

Reversible activation of c-Myc in skin: induction of a complex neoplastic phenotype by a single oncogenic lesion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900294-7

Regulated subset of G1 growth-control genes in response to derepression by the Wnt pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900294-7

Targeting c-Myb expression in human disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900294-7

Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900294-7

Oncogenic activity of the c-Myc protein requires dimerization with Max.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900294-7

New Myc-interacting proteins: a second Myc network emerges

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900294-7

Integrating Myc and TGF-beta signalling in cell-cycle control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900294-7

Increased expression of eukaryotic translation initiation factors eIF-4E and eIF-2 alpha in response to growth induction by c-myc

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900294-7

An essential E box in the promoter of the gene encoding the mRNA cap-binding protein (eukaryotic initiation factor 4E) is a target for activation by c-myc

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900294-7

Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900294-7

Drosophila myc regulates cellular growth during development.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900294-7

c-Myc enhances protein synthesis and cell size during B lymphocyte development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900294-7

Induction of cyclin E-cdk2 kinase activity, E2F-dependent transcription and cell growth by Myc are genetically separable events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900294-7

Direct activation of RNA polymerase III transcription by c-Myc

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900294-7

Identification of a Myc-dependent step during the formation of active G1 cyclin-cdk complexes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900294-7

Repression of c-Myc responsive genes in cycling cells causes G1 arrest through reduction of cyclin E/CDK2 kinase activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900294-7

Direct induction of cyclin D2 by Myc contributes to cell cycle progression and sequestration of p27.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900294-7

Identification of CDK4 as a target of c-MYC.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900294-7

Cyclins D1 and D2 mediate myc-induced proliferation via sequestration of p27(Kip1) and p21(Cip1).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900294-7

Repression of p15INK4b expression by Myc through association with Miz-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900294-7

The novel ATM-related protein TRRAP is an essential cofactor for the c-Myc and E2F oncoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900294-7

Regulation of cyclin D2 gene expression by the Myc/Max/Mad network: Myc-dependent TRRAP recruitment and histone acetylation at the cyclin D2 promoter.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900294-7

The Myc/Max/Mad network and the transcriptional control of cell behavior

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900294-7

c-myc and c-fos expression in differentiating mouse primary keratinocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900294-7

Contrasting roles for Myc and Mad proteins in cellular growth and differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900294-7

Myc and Mad bHLHZ domains possess identical DNA-binding specificities but only partially overlapping functions in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900294-7

Induction of apoptosis in fibroblasts by c-myc protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900294-7

Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900294-7

Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900294-7

The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900294-7

Multiple docking sites on substrate proteins form a modular system that mediates recognition by ERK MAP kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900294-7

E2F1 and c-Myc potentiate apoptosis through inhibition of NF-kappaB activity that facilitates MnSOD-mediated ROS elimination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900294-7

c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: a mechanism for oncogene-induced genetic instability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900294-7

Requirement for the CD95 receptor-ligand pathway in c-Myc-induced apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900294-7

MycN and IFNgamma cooperate in apoptosis of human neuroblastoma cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900294-7

c-Myc-induced sensitization to apoptosis is mediated through cytochrome c release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900294-7

Three-dimensional structure of the apoptosome: implications for assembly, procaspase-9 binding, and activation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900294-7

Breaking the mitochondrial barrier

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900294-7

Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900294-7

Biological activities of v-myc and rearranged c-myc oncogenes in rat fibroblast cells in culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900294-7

Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900294-7

Cooperative interaction between c-myc and bcl-2 proto-oncogenes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900294-7

c-MYC: more than just a matter of life and death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900294-7

Reversible tumorigenesis by MYC in hematopoietic lineages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900294-7

c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900294-7

Transient excess of MYC activity can elicit genomic instability and tumorigenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900294-7

Sustained loss of a neoplastic phenotype by brief inactivation of MYC

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900294-7

Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900294-7

Islet growth and development in the adult

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900294-7

Chronic hyperglycemia triggers loss of pancreatic beta cell differentiation in an animal model of diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900294-7

Critical reduction in beta-cell mass results in two distinct outcomes over time. Adaptation with impaired glucose tolerance or decompensated diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900294-7

Overexpression of c-Myc in beta-cells of transgenic mice causes proliferation and apoptosis, downregulation of insulin gene expression, and diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900294-7

Intramural coronary delivery of advanced antisense oligonucleotides reduces neointimal formation in the porcine stent restenosis model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900294-7

Local intracoronary administration of antisense oligonucleotide against c-myc for the prevention of in-stent restenosis: results of the randomized investigation by the Thoraxcenter of antisense DNA using local delivery and IVUS after coronary stenti

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900294-7

In Vivo Modulation of N-myc Expression by Continuous Perfusion with an Antisense Oligonucleotide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9861%2803%2900294-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0003-9861(03)00294-7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12893289%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference